Dual Orexin OX1/OX2 Receptor Agonists (Orexia)

N/A

Report date: 2025/01/26 18:22:05
NME

Base Information

Drug NameDual Orexin OX1/OX2 Receptor Agonists (Orexia)
Drug Alias Nameorexin receptor agonists (Heptares Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 agonistsOrexin receptor type 2 agonists
TargetsOrexin receptor type 2Orexin receptor type 1
Therapy Area/IndicationsDisorders of Excessive SomnolenceNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma UK Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOrexia Therapeutics
Inactive CompaniesNxera Pharma UK Ltd
Active IndicationsDisorders of Excessive Somnolence
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A